Europe Electrophoresis Market

Europe Electrophoresis Market Size (2024 to 2029)

As per our research report, the Europe Electrophoresis Market size was worth USD 0.65 billion in 2024 and estimated to be growing at a CAGR of 5.1%, to reach USD 0.84 billion by 2029.

On-going research to develop innovative products with the latest technology and raising awareness through campaigns and digital advertisements are the key factors propelling the growth of the market. Growing focus on the use of next-generation sequencing techniques and growth in infectious diseases and prevalence to develop new vaccines further boost the European Electrophoresis market. Besides, the growing aging population is also acting as a contributor to the growth rate of this market.

However, electrophoresis is a time-consuming technique where it is also a factor hindering the growth rate of the market. Fluctuations in the availability of different raw materials and high maintenance cost are primary factors which are declining the growth rate of the market. Lack of skilled people due to less training programs, stringent rules and regulations, and less awareness in utilizing these techniques in undeveloped countries are further restraining the European electrophoresis market growth.

This research report segmented and sub-segmented the Europe Electrophoresis Market into the following categories

Europe Electrophoresis Market Analysis By Product

• Gel Electrophoresis
  • Horizontal
  • Vertical
• Capillary Electrophoresis
• Reagents
• Geldof
• Imaging

Europe Electrophoresis Market Analysis By Application

• Diagnostic
• Research
• Quality Control

Europe Electrophoresis Market Analysis By End Users

• Academic and Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centres

Europe Electrophoresis Market Analysis By Country

• The United Kingdom
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regional Analysis

The UK electrophoresis market is currently holding the highest shares in the European market owing to constant economic growth from the past few years. The rise in the number of people suffering from various health disorders is significantly influencing the market's demand to the extent. The increase in the number of hospitals with the latest equipment is also fuelling the growth rate of the market in the UK.

Germany's electrophoresis market is positioned second in holding the most significant shares of the market. Growing prevalence towards the development of new products with advanced technologies is accelerating the demand of the market. Increasing investments in the healthcare sector by private and public organizations are also elevating the growth rate of the electrophoresis market in this country.

The electrophoresis market in France and Italy is expected to grow faster during the forecast period due to on-going research on the development of various techniques. Also, rising incidences of chronic diseases like cancer and cardiovascular problems are leveraging the market's demand.

Spain, Russia, and the rest of Europe gain traction over the market shares in the coming years. Growing population and creating awareness over the use of electrophoresis techniques are majorly fuelling the market demand. Also, the increasing prevalence of adopting new technologies in medical science is surging the growth rate of the market.

Prominent Companies leading this European Electrophoresis Market Profiled in the Report are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Serbia Group, and C.B.S. Scientific Company.